Iowa

Iowa operates a Medical Cannabidiol Program under the Medical Cannabidiol Act (Iowa Code Chapter 124E), enacted in 2014 and expanded through subsequent legislation. Patients may possess up to 4.5 grams of THC over a 90-day period, with physician waivers available for terminal patients or those requiring higher doses. Qualifying conditions include chronic pain, cancer, PTSD, ALS, seizures, Parkinson's disease, Crohn's disease, and HIV/AIDS, among 14 total conditions. Available product forms include vaporizable preparations, suppositories, topicals, and oral formulations; however, edibles and flower are prohibited. The state currently allows a maximum of 10 dispensary locations. Legislation to expand the dispensary network was under discussion in early 2026.

Ask the Expert about Iowa

Regulator

Iowa Department of Health and Human Services — Office of Medical Cannabidiol

Key Legislation

Iowa Code Ch. 124E

Year Legalized

2014

Program Size

N/A

Key Facts

Patients limited to 4.5 grams of THC per 90-day period; waivers available for terminal patients
14 qualifying medical conditions including chronic pain, PTSD, cancer, and seizures
Edibles and raw flower are prohibited; vaporizable forms, topicals, and oral products are permitted
Maximum of 10 dispensary locations statewide under current law
Program overseen by the Iowa Department of Health and Human Services

Key Legislation

Iowa Code Ch. 124E (Medical Cannabidiol Act)

Regulatory Body

Iowa Department of Health and Human Services — Office of Medical Cannabidiol

Country Info

ISO Code

Region

North America

Tier

Tier 3 — Restricted

Status

Medical — Limited

Sources

Iowa HHS — Medical Cannabis Program Iowa Legislature — Medical Cannabidiol Act (Ch. 124E)Marijuana Policy Project — Iowa Overview

Disclaimer: This information is for general reference only and does not constitute legal advice. Cannabis regulations change frequently. Always verify with official sources and local legal counsel before making compliance decisions.